Clinical Trial

Intravitreal and Intracameral DEX in NPDR

Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Summary
To investigate the effects of intravitreal and intracameral injection of dexamethasone during cataract phacoemulsification in patients with mild to moderate non-proliferative diabetic retinopathy
Trial Details
NCT Number NCT06951087
Lead Sponsor Affiliated Hospital of Nantong University
Conditions Non-Proliferative Diabetic Retinopathy
Enrollment 80 participants
Start Date 2022-01-31
Primary Completion 2025-04-20 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-30